Skip to main content

Table 3 Diagnostic yield of endoscopy

From: Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness

Endoscopic findings N Inappropriate Uncertain Appropriate
No significant findings 261 51 (19.6%) 45 (17.2%) 165 (63.2%)
Clinically-significant findings 112 8 (7.1%) 16 (14.3%) 88 (78.6%)
Reflux esophagitis 44 5 (11.3%) 2 (4.6%) 37 (84.1%)
Erosive gastritis 13 1 (7.7%) 1 (7.7%) 11 (84.6%)
Gastric ulcer 4 0 (0.0%) 0 (0.0%) 4 (100%)
Stomach cancer 2 0 (0.0%) 1 (50%) 1 (50%)
Inflammatory bowel disease 9 0 (0.0%) 4 (44.4%) 5 (55.6%)
Infectious colitis 4 0 (0.0%) 0 (0.0%) 4 (100%)
Adenomatous polyp 20 1 (5.0%) 4 (20.0%) 15 (75.0%)
Colonic cancer 10 0 (0.0%) 2 (20.0%) 8 (80.0%)
Miscellaneous 6 1 (16.7%) 2 (33.3%) 3 (50.0%)
  1. Data are presented as numbers (%). Reflux esophagitis included Los Angeles grade A (N = 22), grade B (N = 11), grade C (N = 3) and grade D (N = 8). Inflammatory bowel disease included Crohn’s disease (N = 4) and ulcerative colitis (N = 5). Miscellaneous included diverticulitis (N = 2), NSAID-induced colitis (N = 2) and unspecified proctitis (N = 2).